Form 4: Maravai LifeSciences CFO Kevin Herde Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Kevin Herde, CFO of Maravai LifeSciences Holdings, Inc., reports the disposal of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 18, 2025, Kevin Herde, the Chief Financial Officer of Maravai LifeSciences Holdings, Inc., disposed of 2,326 shares of Class A Common Stock.
- The transaction was executed to satisfy tax withholding obligations associated with the vesting of restricted stock unit awards.
- The shares were disposed of at a price of $4.1.
- Following the transaction, Herde beneficially owns 287,930 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction (tax-related stock disposal) and doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading disclosures, providing transparency into the transactions of company executives and directors. This specific filing relates to the disposal of shares to cover tax obligations, which is a common practice.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of transaction: Kevin Herde disposed of shares. |
| 02/19/2025 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.